Aktiesnakken — Februar 2012
-
ingen er blevet fattige af profit
-
så vil jeg også kigge lidt på pharma. Eli Lilly, GSK og Johnson&Johnson. Lidt parantes om GSK hvis sidste regnskab måske ikke var så lovende
-
men de køber mange aktier op underneden
-
der er mange dygtige folk herinde. Jeg er en slags vicevært
-
dont do SAS it will do you
-
når jeg må til møde vi ses senere
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind